Open access
8,475
Views
0
CrossRef citations to date
0
Altmetric
Review
Drug metabolism in the lungs: opportunities for optimising inhaled medicines
Zachary Enlo-Scotta Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College London, London, UK
, Erica Bäckströmb Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
, Ian Mudwayc MRC Centre for Environment and Health, School of Population Health & Environmental Sciences, Imperial College London, London, United Kingdom; National Institute for Health Research, Health Protection Research Units in Chemical and Radiation Threats and Hazards and Environmental Exposures and Health, Imperial College London, London, UK
& Ben Forbesa Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King’s College London, London, UKCorrespondence[email protected]
https://orcid.org/0000-0001-8193-6107
Pages 611-625
|
Received 15 Feb 2021, Accepted 22 Mar 2021, Published online: 21 Apr 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.